Viking Global Investors
INSM icon

Viking Global Investors’s Insmed INSM Stock Holding History

Viking Global Investors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,035,970
Closed -$69.4M – 95
2024
Q2 		$69.4M Buy
+1,035,970
New +$40.2M 0.27% 64

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors's INSM Position: Q3 2024 in Review

Viking Global Investors sold out of Insmed (INSM) in Q3 2024, closing a stake of 1,035,970 shares — an estimated $69.4M sold.

Viking Global Investors first reported a position in INSM in Q2 2024 and held it in 1 quarter. The position peaked at $69.4M in Q2 2024. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

  • Viking Global Investors reported no remaining Insmed position as of Q3 2024 after selling out during the quarter.
  • Viking Global Investors sold 1,035,970 Insmed shares in Q3 2024, an estimated $69.4M.
  • Viking Global Investors first reported a position in Insmed in Q2 2024 and held it in 1 quarter.
  • Viking Global Investors's Insmed position peaked at $69.4M in Q2 2024.
  • 413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Viking Global Investors's 13F filing for Q3 2024, filed 14 Nov 2024.